Tirzepatide's dual-action approach Tirzepatide (found in Mounjaro and Zepbound) works differently by activating not one, but two hormone receptors: GLP-1 receptors (the same ones that semaglutide targets) GIP (glucose-dependent insulinotropic polypeptide) receptors This dual-action approach creates complementary effects on hunger, metabolism, and blood sugar regulation and yielding more impactful results than GLP-1 alone
Limitations of the TRIUMPH-1 results The results of TRIUMPH-1 have only come through a press release, not the publication of a peer-reviewed journal
Tirzepatide provides key benefits such as enhanced glucose control, appetite regulation, sustainable weight loss, and improved cardiovascular health, aligning with our commitment to enhancing physical health and overall quality of life
Wait 3 months if a piercing was performed using a reusable gun or any reusable instrument
Pitfall #4: Neglecting Follow-Up Weight loss requires ongoing management